Image

Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children

Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children

Recruiting
3-15 years
All
Phase N/A

Powered by AI

Overview

The goal of the clinical study is to clarify the course of common congenital, infectious, and non-infectious diseases in children living in Uzbekistan, and to develop methods for their treatment and rehabilitation.

The main questions it aims to answer:

  • Analysis of common congenital diseases among children;
  • Analysis of commonly diagnosed bronchopulmonary and cardiovascular diseases among children;
  • Based on the results of the primary research, common diseases among children will be identified;
  • Analysis of existing treatment methods and their effectiveness;
  • Development of modern methods of treatment and rehabilitation of children.

Description

Children's health is a priority in modern medicine. Some childhood diseases are most often encountered in the practice of pediatricians and family doctors. Children with these diseases need early diagnosis, treatment, and rehabilitation.

Patient selection criteria are:

  • children from birth to 15 years;
  • children permanently residing in the territory where the clinical examination is carried out;
  • children included in the group of "frequently ill children";
  • patients without severe chronic diseases.

Exclusion criteria:

  • Teenagers over 15 years old;
  • Patients with severe neurological and mental diseases;
  • Patients with endocrinological diseases;
  • Patients with long-term chronic somatic diseases;
  • Children without genetic pathologies.

Clinical research methods:

  • Collection of anamnestic data;
  • General examination of patients (auscultation, palpation, percussion);
  • If necessary: consultation with a geneticist and pediatric doctors of various specialties (cardiologist, surgeon, urologist, nephrologist, otolaryngologist, pulmonologist, immunologist, allergist)
  • Standard laboratory tests (general analysis of blood, urine, feces);
  • Standard biochemical studies (microelements of blood and enzymes in venous blood);
  • Instrumental studies: chest X-ray, ultrasound examination of internal organs (chest and abdominal organs), computed tomography (chest and abdominal organs);
  • Study of immunological status (cellular immunity, according to standard methods); Immunological research methods - flow cytometry, mIU/mL: immunogram - CD3, CD3/4, CD3/8, CD19, CD16/56, CD3/16/56, CD3/HLA-; and others;
  • Study of antioxidant status (TAS, using the PSR method, mmol/L);
  • Assessing the quality of life of patients (methods: PedsQLtm 4.0; HBSC, indicator: total score on the screening survey).

Eligibility

Inclusion Criteria:

  • children from birth to 15 years;
  • children permanently residing in the territory where the clinical examination is carried out;
  • children included in the group of "frequently ill children";
  • patients without severe chronic diseases.

Exclusion Criteria:

  • Teenagers over 15 years old;
  • Patients with severe neurological and mental diseases;
  • Patients with endocrinological diseases;
  • Patients with long-term chronic somatic diseases;
  • Children without genetic pathologies.

Study details
    Respiratory Diseases
    Congenital Heart Defects

NCT06267859

Tashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan

27 May 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.